Healthcare
Gilde Healthcare exits Stat-DX
Gilde Healthcare led a €31m funding round for molecular diagnostic specialist Stat-DX in 2016
Nordic Capital sells remaining shares in ConvaTec
With shares priced at 220 pence apiece, total gross proceeds amounted to ТЃ315m in the final sell-off
Yabeo et al. in $17m series-A for Cera
Online elderly care platform will expand into Germany and across the UK following the deal
Axcel acquires Orion Diagnostica in €163m deal
Deal is the fourth investment from Axcel V, which held a тЌ617m final close in April 2018
Andera leads $70m series-B for Crescendo Biologics
UK-based biotechnology company will progress its lead programme to the clinical stage
Sofinnova leads €26.5m round for EryDel
Existing shareholders Genextra and Innogest also take part in the investment round
Sofinnova leads €35.5m capital increase for Inventiva
Capital is drawn from Sofinnova Crossover Fund I, which held a final close on €275m in April 2018
NB Renaissance Partners et al. exit Esaote
Chinese consortium wholly acquires the Italian medical imaging company
Andera et al. in €20m series-A for MMI
VC houses Panakès Partners and Fountain Healthcare Partners also took part in the funding round
Vesalius et al. lead $4.6m round for Sword Health
Vesalius deployed capital from its Vesalius Biocapital III fund, which was launched last year
Sofinnova et al. back €27m series-C for Limflow
BPI France and Balestier, a Singaporean family fund, also take part in the financing
Turenne Capital invests €9.8m in Infimed
Turenne acquires a majority stake in the medical device financing business through the transaction
Gilde Healthcare's Rad-X buys TelradKo
Acquisition will provide TelradKo with fresh capital to accelerate its expansion
Advent International in €1.91bn Zentiva carve-out
GP to buy generics business division Zentiva from French biopharmaceutical company Sanofi
Charterhouse's Cooper-Vemedia buys 12 Sanofi brands for €158m
Deal is the second major bolt-on acquisition for the group since the GP acquired it in 2015
VC firms back £29m series-B for Enterprise Therapeutics
Forbion, Versant, Novartis, Epidarex and IP Group all take part in the financing
PE-backed Wilson Therapeutics in SEK 7.1bn trade sale
Alexion Pharmaceuticals announces a public cash offer to acquire Wilson for SEK 232 per share
Adiuva Capital-backed AC Dental buys NT Dental
Adiuva generally makes investments between €5-40m for majority and minority positions
Folmer exits Jatkopolut to Familar
Familiar is a subsidiary of healthcare and social services firm MehilУЄinen, backed by Triton and KKR
Capvis, Partners Group buy Amann Girrbach from TA
Capvis draws equity from its new DACH-focused buyout fund Capvis Equity V, targeting €1bn
Benelux's biotech and pharma buyouts market in rude health
Buyout houses are becoming more attracted to assets in the Benelux biotech and pharma spaces, typically the preserve of venture capital investors
Investindustrial acquires Lifebrain
Lifebrain was initially funded with capital raised from several Austrian private investors
ArchiMed buys Soest Medical
GP draws equity from its €315m Med II vehicle, which held a final close on its hard-cap in September
CDPQ-backed Datamars acquires Simcro from Riverside
Deal brings a five-year holding period for private equity firm The Riverside Company to an end